Skip to main content

Kathryn Eve Flynn

Adjunct Professor in the Department of Population Health Sciences
Population Health Sciences
Box 3850 Med Ctr, Durham, NC 27710
2400 Pratt St, Durham, NC 27710

Overview


Kathryn E. Flynn, PhD, is an adjunct assistant professor in psychiatry and behavioral sciences at the Duke University School of Medicine. She works primarily at the Duke Clinical Research Institute.

Dr. Flynn was trained in sociology and population health sciences at the University of Wisconsin, where she worked with Maureen Smith on the development and fielding of new survey instruments to assess health care access and utilization in the near elderly as part of the Wisconsin Longitudinal Study, a long-term cohort study with over 10,000 participants. In 2005, Dr. Flynn was awarded an R36 dissertation grant from the Agency for Healthcare Research and Quality to use the Wisconsin Longitudinal Study to examine preferences for health care decision making among older adults. Findings from this research have been published in Social Science and Medicine and the Journal of General Internal Medicine. As a postdoctoral fellow at the Duke Clinical Research Institute, Dr. Flynn trained under Kevin Weinfurt, gaining experience in the design and analysis of patient-reported outcomes in clinical trials.

Dr. Flynn's research interests include shared medical decision making; patient-provider relationships, including communication, trust, and technology; quality of medical care; patient-reported outcomes in clinical trials; and quantitative and qualitative methods in behavioral research.

Areas of Expertise: Health Measurement, Health Services Research, and Health Behavior

Current Appointments & Affiliations


Adjunct Professor in the Department of Population Health Sciences · 2018 - Present Population Health Sciences, Basic Science Departments

Recent Publications


Expert consensus definition of treatment intolerance in chronic myeloid leukemia in chronic phase.

Journal Article Hematology · December 2025 INTRODUCTION: Chronic myeloid leukemia in the chronic phase (CML-CP) has undergone therapeutic transformation with the advent of BCR::ABL1 tyrosine kinase inhibitors (TKIs), improving 10-year survival rates from 20% to ∼90%. These outcomes place increasing ... Full text Link to item Cite

Leveraging the perspectives and experiences of landlords and property managers for lead poisoning prevention

Journal Article Discover Public Health · December 1, 2025 Background: Children residing in rental properties are at risk for lead exposure. This study examines experiences of landlords related to lead poisoning. Data & methods: An electronic survey was distributed nationally to a convenience sample of landlords a ... Full text Cite

Lead Service Lines and Infant Blood Lead Levels.

Journal Article JAMA Netw Open · December 1, 2025 Full text Link to item Cite
View All Publications

Recent Grants


Validating and Extending the PROMIS Sexual Function Measure for Clinical Research

ResearchCo Investigator · Awarded by National Institutes of Health · 2009 - 2015

Decision Making by Patients Seeking Care for Fertility Problems

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2012 - 2012

HF Action Supplement

Clinical TrialHealth Economist · Awarded by National Institutes of Health · 2002 - 2010

View All Grants

Education, Training & Certifications


University of Wisconsin, Madison · 2005 Ph.D.